HighTower Advisors’s MiNK Therapeutics INKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,068
| Closed | -$35.3K | – | 3582 |
|
|
2024
Q4 | $35.3K | Sell |
5,068
-105
| -2% | -$732 | ﹤0.01% | 3420 |
|
|
2024
Q3 | $36K | Buy |
5,173
+104
| +2% | +$724 | ﹤0.01% | 3391 |
|
|
2024
Q2 | $43K | Sell |
5,069
-19
| -0.4% | -$161 | ﹤0.01% | 3272 |
|
|
2024
Q1 | $43K | Sell |
5,088
-6
| -0.1% | -$51 | ﹤0.01% | 3215 |
|
|
2023
Q4 | $49K | Buy |
5,094
+3,453
| +210% | +$33.2K | ﹤0.01% | 3240 |
|
|
2023
Q3 | $13K | Sell |
1,641
-57
| -3% | -$452 | ﹤0.01% | 3273 |
|
|
2023
Q2 | $30K | Buy |
1,698
+658
| +63% | +$11.6K | ﹤0.01% | 3163 |
|
|
2023
Q1 | $18K | Hold |
1,040
| – | – | ﹤0.01% | 3072 |
|
|
2022
Q4 | $27K | Hold |
1,040
| – | – | ﹤0.01% | 3028 |
|
|
2022
Q3 | $22K | Buy |
+1,040
| New | +$22K | ﹤0.01% | 2897 |
|